Gastric Bypass Companies

Gastric Bypass Market Overview

The Gastric Bypass Market is expected to reach USD 1.61 Billion by 2032 at 4.9% CAGR during the forecast period 2023-2032. Gastric bypass is a surgical treatment that reduces the size of the stomach and its capacity to store food. Gastric bypass, adjustable gastric band, sleeve gastrectomy, and biliopancreatic diversion with duodenal switch are all common bariatric surgical methods for reducing stomach size. The stomach is separated into upper and lower pouches during gastric bypass, so food reaches the small intestine straight after passing through the stomach. Obesity, defined as a BMI of more than 40, is well treated with surgery. Other reasons for gastric bypass surgery include gastroesophageal reflux illness, heart disease, hypertension, and type 2 diabetes.

The rising incidence of obesity, diabetes, and cardiovascular disease, as well as the growing desire for minimally invasive surgery, are propelling the market forward globally. In addition, the employment of modern technological gadgets in health care facilities for surgical procedures has an impact on market growth.

Gastric Bypass Market Segmentations

The global gastric bypass market is segmented on the basis of type, indication, and end user.

On the basis of the type, it is segmented into endoscopic sleeve gastroplasty and intragastric balloon.

Based on the indication, it is segmented into obesity, gastroesophageal reflux disease, heart disease, high blood pressure, type 2 diabetes, and others.

On the basis of the end user, it is segmented into hospitals & clinics, surgical centers, and others Figure: Global Gastric Bypass Market, By Region, 2016 (%) 

Gastric Bypass Market- Key Players

Some of key the players in the market are Medtronic (U.S.), Intuitive Surgical Inc. (U.S.), TransEnterix Inc.  (U.S.), ALLERGAN (Republic of Ireland), USGI Medical Inc. (U.S.), Cousin Biotech (France), GI Dynamics Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Mediflex Surgical Product (U.S.), and others.

Sources: Annual reports, Press release, White paper, Company presentation

Gastric Bypass Market- Regional Analysis

The Americas are the largest gastric bypass market across the globe owing to well-developed technology, increasing the prevalence of obesity and cardiovascular diseases, availability of healthcare specialty healthcare services, and technologically advancement in the field of healthcare. In North America, the U.S. dominates the market owing to an increased number of market players manufacturing surgical devices. Additionally, in the U.S., gastric bypass is one of the most common procedures for obesity, and other major indications such as diabetes, and gastroesophageal reflux disease. Furthermore, the prevalence of diabetes is found to be increasing among the U.S. population. As per the National Diabetes Statistics Report of the Center for Disease Control and Prevention (CDC), in 2015, 9.4% of the U.S. population i.e. 30.3 million people had diabetes.

Europe holds the second position in the global gastric bypass market owing to the increasing diabetic population. Additionally, extensive research & development activities in the field of gastroenterology and availability of funds for research also fuel the market growth. Germany and France are the largest contributors to the market owing to increasing use of minimally invasive surgical procedures in hospitals, and surgical centers.    

The Asia Pacific is the fastest growing gastric bypass market owing to the ever-increasing prevalence of diabetes and cardiovascular diseases and demand for technologically advanced devices for minimally invasive surgical procedures. India and China are the major contributors to large diabetic patient pool and increasing number of specialty services. Additionally, the growth of the medical technology and healthcare industry in developing economies of Asia Pacific also influence the growth of the market. Furthermore, increasing demand for quality care services and new devices in the healthcare are expected to increase the use of advanced medical devices and instruments.  

In the Middle East & Africa, prevalence of obesity and diabetes is increasing from last few years. This increase in the prevalence is attributed to sedentary lifestyle, and lack of physical exercise. In Africa, the prevalence of non-communicable diseases is increasing at a steady rate along with communicable diseases, thus signifying the need for effective therapeutic options of treatment of diseases.Recent Development

The Incisionless Operating PlatformTM from USGI Medical, which includes the g-CathTM EZ Delivery Catheter with Snowshoe® suture anchors, g-Prox® EZ, g-LixTM, and Transport®, reduces the need for external abdominal incisions by giving doctors the tools they need to perform minimally invasive procedures through a patient's mouth or other natural orifices. Notably, USGI Medical has established the capacity to fixate and plicate stomach tissue consistently and durably without the use of an incision.

According to Emergent Research's latest estimate, the worldwide bariatric surgery market is predicted to reach USD 4.81 billion by 2028, with a stable CAGR of 9.0 percent. Worldwide obesity concerns are driving the global bariatric surgery market's revenue growth to a large extent. Obesity is a serious public health issue that has fueled the demand for gastric bypass surgery in nations all over the world. Concerns about infection after surgery are a major factor causing some people to be hesitant to undergo procedures, which is limiting the market growth.

Intended Audience

• Medical Devices Companies


• Research and Development (R&D) Companies


• Government Research Institute


• Academic Institutes and Universities

Research Methodology 

Sources: Annual reports, Press release, White paper, and Company presentation